Meet with our product experts in one-on-one virtual sessions
Set Up a Meeting
Nota informativa
Tech Sheet – Mirabegron API
Tech sheet – Apremilast
Product Alert - Relugolix API
Tech Sheet on Enzalutamide Premix
Product Alert – Mirogabalin Besylate
Product Alert – Vonoprazan Fumarate
Substantially Pure Carfilzomib Amorphous for Generic Launch
Tech sheet: Dr. Reddy's Olaparib API Offerings
Product Alert – Mavacamten API
Product Alert – Niraparib API
Product Alert – Tucatinib API
Product Alert – Daprodustat
Tech Sheet - Cabozantinib (S)-malate API
Product Alert – Deucravacitinib API
Tech Sheet – Mirabegron API
White Paper on Sugammadex API
Tech Sheet on Pregabalin API
Product Alert – Pazopanib API
Tech Sheet on Midostaurin API
Tech Sheet on Tofacitinib Citrate
Tech Sheet on Linagliptin
Tech Sheet on Dutasteride
Tech Sheet on Voriconazole
Tech Sheet on Nilotinib Hydrochloride
Addressing the presence of mutagenic Azido impurities in Sartan APIs
Co-Crystal and Customized Particle Size for Early Launch Opportunity of Siponimod API
New Product Alert – Lumateperone Tosylate API
Tech sheet: Dr. Reddy's Bempedoic Acid API Offerings
Tech sheet: Dr. Reddy's Enzalutamide API Offerings
Tech Sheet - Dr. Reddy’s Eribulin Mesylate API offerings
Tech Sheet – Dr. Reddy’s Fexofenadine API offerings
Tech Sheet - Dr. Reddy’s Azacitidine API offerings
Tech Sheet - Dr. Reddy’s Ramipril API offerings
Tech Sheet - Dr. Reddy’s Gemcitabine API offerings
Tech Sheet: Dr. Reddy’s Abiraterone Acetate API offerings
White Paper: Redyx: Remdesivir formulation developed at Dr. Reddy’s under the license from Gilead
Whitepaper : Dr.Reddy's 2 DG- A promising treatment in hospitalized COVID-19 patients
Techsheet: Dr.Reddy's Lenvatinib API offerings
ROXADUSTAT - a multipronged development strategy
Dr.Reddy's Apremilast API and finished formulation offerings.
Dr. Reddy’s Fosaprepitant API offerings
Apixaban API – ready-to-compress granules and finished dosage forms
Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies
Colloidal Iron Complex Formulations – Understanding and Developing the Process
Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations
Dr. Reddy's Mirabegron API offering in both alpha and amorphous form
Palbociclib – how a novel process development approach provides IP advantages
Dr. Reddy's Elagolix API offering leverages a well rounded Quality by Design approach
Sacubitril/Valsartan (LCZ696) – Bringing yet another advantage through innovative API offerings
Dr. Reddy’s Flow Chemistry experts share their perspectives in panel discussion of Chemistry Today
A closer look on how Dr. Reddy's met the stringent regulatory requirement of genotoxic impurities in Ranolazine
Famotidine and Nizatidine APIs: NDMA controlled, customized particle distribution, supply chain security
Meeting the New Regulatory Requirements in Sartan API Production
Artículos
A year of growth & Sustainability
Understanding Nitrosamines and GTI Issues in APIs: A Comprehensive Overview with Dr. Reddy's Perspective
Innovative Approaches to API Production in 2024: Shaping the Future of Pharma Companies
Continuous Manufacturing Process and Its Impact on Pharma Manufacturing
Development of Niche Products at Dr. Reddys API
Streamlining the Process: Preparing a Pharmaceutical Composition of Fosaprepitant API
A Comparative Study on Naproxen Formulations
An effective strategy for the development of docetaxel
Preformulation Studies for Generic Omeprazole
A comparative study on enzalutamide Formulations
Navigating the Heart of Pharmaceuticals: An In-Depth Exploration of Active Pharmaceutical Ingredient Manufacturing for Essential Medicines
Presence of Organic Impurities in active pharmaceutical ingredients: An Overview
Strategies and Technologies for Enhancing Cost-Effectiveness in Active Pharmaceutical Ingredient (API) Production
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Refractory Chronic Lymphocytic Leukemia
Demonstrating Equivalence of Generic Glatiramer Acetate: Ensuring Quality and Safety
Ensuring Drug Safety: Comprehensive Analysis of Active Pharmaceutical Ingredient Lists
Unravelling the Science: Pharmaceutical Compositions and Process of Levetiracetam API
Steps taken by Dr. Reddy's Laboratories in controlling the environmental risks and safety management in the manufacturing of APIs
Meeting the New Regulatory Requirements and Controlling of Nitrosamine Impurities in Sartan API Production
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients
Reshaping the Pharmaceutical API Industry with Digital Transformation
7 Ways how Active Pharmaceutical Ingredients (APIs) Enable Indian Pharmaceutical Companies to Grow
How is the Indian Pharmaceutical industry gearing up for 2022-2023?
Impact of COVID-19 on Indian HPAPI industry
The synthesis of active pharmaceutical ingredients (APIs) using continuous flow chemistry
ANVISA Certification of GMP Pharmaceutical Ingredients for 61 of Dr Reddy’s APIs
Managing the Product Life Cycle: Naproxen API and formulations
Understanding Active Pharmaceutical Ingredients: CPHI talk by Dr. Ramani Susarla
EMA Nitrosamine Guidance – Deadline March 31, 2021
Patient centricity and supply chain security in 2021 - Rajesh Sadanandan speaks on CPhI Pharma Trends 2021
Dr. Reddy's research publication on simultaneous automated image analysis and Raman spectroscopy of powders at an individual particle level
COVID-19 and What’s Next for API Sourcing?
A Paradigm Shift that Is Here to Stay - Sauri Gudlavalleti speaks to CME Manager on COVID-19 response
A Year of Challenge and Opportunity - Deepak Sapra, Global Head of PSAI speaks to The Medicine Maker
Indian healthcare reform offers thriving pharmaceutical market opportunities: Interview with Deepak Sapra
Dr. Reddy’s is improving supply chain performance for Pregabalin API through large manufacturing capacity and backward integration
Enhancing Supply Chain Security for Levetiracetam API
Noticias
Gunjan Singh at the CPHI Webinar: The Changing Dynamics of Global API Manufacturing
Karun Gaur at CPHI Milan: Panel Discussion on Pharma Manufacturing in Emerging Markets - Moving Towards Localization in Africa
Deepak Sapra's Visionary Keynote on Healthcare Innovation at DXEM 2024
Dr. Reddy's AI Day: Igniting the Future of Healthcare with Innovation
Dr. Reddy’s at CPHI India 2023
Dr. Reddy’s API at CPHI Worldwide 2023
Dr. Reddy’s API at CPHI China 2023
Dr. Reddy’s API at CPHI Japan 2024
Asia-Pacific Climate Leader Award
Dr. Reddys at G20 Summit 2023
Dr. Reddys Strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya
USP recognized Dr. Reddy’s with a crystal award for significant contribution towards “New and modernized monograph submissions”
Dr. Reddy's API Calendar 2024 Unveiling: A Magical Celebration of Creativity, Joy, and Togetherness with Our Global Team's Talented Young Artists
Dr. Reddy's Pioneers Pharma Advancements Through Strategic Partnerships and Innovation: A Glimpse into Vision 2030: Growth Trajectory and Opportunities for Indian Pharma
Dr. Reddy’s at 5th CII LIFE SCIENCES SUMMIT 2023 - Making India a Global Pharma and Lifesciences Innovation Hub
Dr. Reddy’s Achieves AEO-T3 Certification, Elevating Global Trade Facilitation
Being Prepared for What's Next and a Shared Purpose of Serving Patients Whatever it Takes
Dr. Reddy’s included in Bloomberg Gender-Equality Index for the 6th year in a row and S&P Global’s Sustainability Yearbook for the 3rd year
Expert statement by Srividya Ramakrishnan, Head, API process engineering, Dr. Reddy’s Laboratories. Published in CHE Manager
Dr. Reddy's API calendar 2023
Addressing NDMAs in Pharmaceuticals
Dr. Reddys attended ACHEMA 2022 Conference
Dr. Reddy's API participated in the 2022 Pharmaceutical Industry and Regulators Symposium at ANVISA
Dr.Reddy's at CPHI India 2022 Panel Discussion
Dr. Reddy’s API received the excellence in API – Technical Documentation award at Aché Laboratórios Parcerias para a Excelência (Partnerships – Excellence) event!
Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards
COVID-19: Prime Minister of India Meets Pharma leaders
The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards
Dr. Reddy's at CPHI 2021
The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021
Sugammadex Sodium API – CADIFA Approval by ANVISA
Deepak Sapra speaks about DRDO’s anti-covid drug 2DG
Dr.Reddy’s gearing up with Covid portfolio: Deepak Sapra, CEO of API & Services, speaks to India Today
Best Supply Chain Team of the Year - Pharma- 2021
Dr. Reddy’s Laboratories’ Anil Patni presented on HPAPIs at Manufacturing Chemist Live Virtual
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020
Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’
Dr. Reddy’s Laboratories joins Science Based Targets initiative (SBTi) and sets 2030 GHG emission targets
CPhI Festival of Pharma Panel discussion: Innovation Across Borders: How Pharma and innovators are fighting Back Against COVID-19 and ways forward.
CPhI Festival of Pharma Roundtable: Tackling Nitrosamine Contamination
Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19
Dr. Reddy’s is featured in an article of Global Pharma Insights on “Nitrosamine contamination: pharma’s re-evaluation of its supply chain”
Dr. Reddy’s statement on the COVID-19 pandemic
Certificate of Suitability (CEP) granted for Levofloxacin Hemihydrate
US DMF for Apalutamide - Now available
Dr. Reddy's Sustainability Report 2018-19
Dr. Reddy's API Team moves into its new office in China
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2019
Seminarios web
Building Resilience and Agility in the Pharma Supply Chain
Sartans: New Mutagenic Impurities – Azido Impurities
Challenges and Opportunities of Green Chemistry in the Pharmaceutical Industry
The importance of API particle size on formulation success
Eventos
CPHI China 2024
CPHI India 2024
CPHI Milan 2024
CPHI Japan 2024
DCAT 2024
CPHI India
CPHI Worldwide 2023
DCAT 2023
CPHI JAPAN 2023
Korea Science Day 2023
Tech Sheet - Dr. Reddy’s Gemcitabine API offerings
Actualizaciones
Product Name - Lenalidomide Form-A
Japan DMF
Product Name - Linagliptin Form A+B
Brazil DMF
Product Name - Edaravone
Brazil DMF
Product Name - Ripretinib
USDMF
Product Name - Ripretinib
Brazil DMF
Product Name - Vonoprazan Fumarate
USDMF
Product Name - Vonoprazan Fumarate
Brazil DMF
Product Name - Ondansetron
Canada DMF
Product Name - Dabigatran Etexilate Mesylate
Russia DMF
Product Name - Permethrin BPC cis trans 25 75
Korea DMF
Product Name - Lomustine
China DMF
Product Name - Pantoprazole Sodium Sesiquihydrate
China DMF
Product Name - Donepezil Hydrochloride Monohydrate (Form-1)
CEP Granted
Product Name - Relugolix
USDMF
Product Name - Ruxolitinib Phosphate
USDMF
Product Name - Lenvatinib Mesylate (Form-C)
Canada DMF
Product Name - Levocetirizine Dihydrochloride
CEP Granted
Product Name - Irbesartan
CEP Granted
Product Name - Relugolix Sodium
Brazil DMF
Product Name - Ruxolitinib Phosphate
Brazil DMF
Product Name - Carfilzomib
China DMF
Product Name - Decitabine
Korea DMF
Product Name - Cabazitaxel
Taiwan DMF
Product Name - Ketorolac Tromethamine
Saudi Arabia DMF
Product Name - Enzalutamide
Canada DMF
Product Name - Dasatinib Monohydrate
Australia DMF
Product Name - Lenvatinib Mesylate Form-C
Australia DMF
Product Name - Empagliflozin Crystalline [Micronized]
Australia DMF
Product Name - Sacubitril/Valsartan
Australia DMF
Product Name - Dabigatran Etexilate Mesylate
CEP Submitted
Product Name - Sacubitril Sodium
USDMF
Product Name - Benztropine Mesylate
Saudi Arabia DMF
Product Name - Dimethyl Fumarate
Saudi Arabia DMF
Product Name - Memantine Hydrochloride
Russia DMF
Product Name - Sitagliptin Phosphate Monohydrate
USDMF
Product Name - Cabozantinib (S)-Malate [Form N-2]
Brazil DMF
Product Name - Sacubitril Sodium
Brazil DMF
Product Name - Ferric Carboxy Maltose
China DMF
Product Name - Ezetimibe
Brazil DMF
Product Name - Sitagliptin Phosphate Monohydrate
Brazil DMF
Product Name - Dasatinib Monohydrate
Brazil DMF
Product Name - Dabigatran Etexilate Mesylate
USDMF
Product Name - Sumatriptan succinate
CEP Granted
Product Name - Abiraterone Acetate
Brazil DMF
Product Name - Pregabalin
Brazil DMF
Product Name - Sumatriptan succinate
Brazil DMF
Product Name - Apalutamide Form-B
Brazil DMF
Product Name - Esomeprazole Magnesium Trihydrate
CEP Granted
Product Name - Atorvastatin Calcium Trihydrate (Form-1) USP
China DMF
Product Name - Tafamidis Meglumine
USDMF
Product Name - Pemetrexed Disodium (Heptahydrate)
Korea DMF
Product Name - Fosaprepitant Dimeglumine
USDMF
Product Name - TBA-7A / Sitagliptin N-Boc Acid
USDMF
Product Name - Salcaprozate Sodium
USDMF
Product Name - Cabozantinib Hydrochloride
USDMF
Product Name - Lumateperone Tosylate
USDMF
Product Name - Clopidogrel Bisulphate [Form-II] USP DIFA
Brazil DMF
Product Name - Cetirizine Dihydrochloride USP
Brazil DMF
Product Name - Fluoxetine Hydrochloride USP
Brazil DMF
Product Name - Lenvatinib Mesylate (Form C)
Brazil DMF
Product Name - Pioglitazone Hydrochloride USP
Brazil DMF
Product Name - Pioglitazone Hydrochloride Ph. Eur
Brazil DMF
Product Name - Pantoprazole Sodium Sesquihydrate
Brazil DMF
Product Name - Levofloxacin Hemihydrate Ph.Eur
Brazil DMF
Product Name - Pemetrexed Disodium (Heptahydrate)
CEP Granted
Product Name - Nilotinib Hydrochloride Monohydrate
Canada DMF
Product Name - Dimethyl Fumarate
China DMF
Product Name - Montelukast Sodium
China DMF
Product Name - Voriconazole CIP
China DMF
Product Name - Nilotinib Hydrochloride
China DMF
Product Name - Rivastigmine
China DMF
Product Name - Valsartan
Japan DMF
Product Name - Abiraterone Acetate
Korea DMF
Product Name - Naratriptan Hydrochloride
Korea DMF
Product Name - Enzalutamide
Taiwan DMF
Product Name - Enzalutamide
Singapore DMF
Product Name - Ciprofloxacin Hydrochloride
China DMF
Product Name - Telmisartan
GCC DMF
Product Name - Bortezomib
Egypt DMF
Product Name - Sugammadex Sodium
Japan DMF
Product Name - Midostaurin
Australia DMF
Product Name - Ramipril
Russia DMF
Product Name - Moxifloxacin Hydrochloride
Singapore DMF
Product Name - Pantoprazole Sodium Sesquihydrate
CEP Granted
Product Name - Nilotinib Hydrochloride Monohydrate
CEP Granted
Product Name - Tofacitinib Citrate
Brazil DMF
Product Name - Rabeprazole Sodium
Russia DMF
Product Name - Esomeprazole Magnesium Trihydrate
China DMF
Product Name - Linagliptin
Australia DMF
Product Name - Liraglutide
Europe DMF
Product Name - Gatifloxacin Anhydrous
Brazil DMF
Product Name - Varenicline Tartrate
USDMF
Product Name - Olaparib [Form-A]
China DMF
Product Name - Fosaprepitant Dimeglumine
Brazil DMF
Product Name - Pregabalin
Canada DMF
Product Name - Apixaban
Australia DMF
Product Name - Sitagliptin hydrochloride Monohydrate
Saudi Arabia DMF
Product Name - Azacitidine
Egypt DMF
Product Name - Linagliptin
Saudi Arabia DMF
Product Name - Dapagliflozin Amorphous
EUDMF
Product Name - Omeprazole Magnesium
USDMF
Product Name - Fexofenadine HCl Form I
Brazil DMF
Product Name - Cabazitaxel
Egypt DMF
Product Name - Sugammadex Sodium
Singapore DMF
Product Name - Liraglutide
Canada DMF
Product Name - Varenicline Tartrate
Brazil DMF
Product Name - Ferric Carboxymaltose
EUDMF
Product Name - Pantoprazole Sodium
EUDMF
Product Name - Nilotinib Hydrochloride Monohydrate
Korea DMF
Product Name - Dapagliflozin (Amorphous)
Israel DMF
Product Name - Roxadustat Form-A
China DMF
Product Name - Nilotinib Hydrochloride Monohydrate
Australia DMF
Product Name - Tafamidis Meglumine
Brazil DMF
Product Name - Lansoprazole
China DMF
Product Name - Ferric Carboxy Maltose
Australia DMF
Product Name - Dapagliflozin Amorphous
Russia DMF
Product Name - Mirabegron
Egypt DMF
Product Name - Cabozantinib (S)-Malate [Form N-2]
USDMF
Product Name - Cabozantinib Intermediate (CZT3)*
USDMF
Product Name - Ezetimibe (EZE)
USDMF
Product Name - Lumateperone Tosylate
Brazil DMF
Product Name - Roxadustat
Brazil DMF
Product Name - Pantoprazole sodium sesquihydrate (Form-I) Ph. Eur
Brazil DMF
Product Name - Rabeprazole sodium Ph. Eur
Brazil DMF
Product Name - Carfilzomib
Brazil DMF
Product Name - Lenalidomide Form-A
China DMF
Product Name - Dabigatran Etexilate Mesylate
CEP Granted
Product Name - Mirabegron (Alpha Form)
CEP Granted
Product Name - Lenvatinib Form-C
Korea DMF
Product Name - Capecitabine
Korea DMF
Product Name - Dasatinib Monohydrate
Korea DMF
Product Name - Siponimod Hemifumarate
US DMF filed
Product Name - Bempedoic Acid
US DMF filed
Product Name - Risperidone [Form-1]
Brazil DMF Filed
Product Name - Sacubitril + Valsartan Crystalline
Brazil DMF Filed
Product Name - Ramipril
Brazil DMF Filed
Product Name - Levofloxacin Hemihydrate
Brazil DMF Filed
Product Name - Voriconozole
Brazil DMF Filed
Product Name - Apremilast [Amorphous]
Brazil DMF Filed
Product Name - Apremilast [Form-B]
Brazil DMF Filed
Product Name - Siponimod Hemifumarate
Brazil DMF Filed
Product Name - Metoprolol Succinate
China DMF filed
Product Name - Dapagliflozin PG Solvate
China DMF filed
Product Name - Pemetrexed Disodium Heptahydrate
China DMF filed
Product Name - Clopidogrel Bisulphate [Form-1]
Japan DMF filed
Product Name - Rivaroxaban
Japan DMF filed
Product Name - Lenalidomide [Form-A]
Japan DMF filed
Product Name - Naratriptan Hydrochloride
Japan DMF filed
Product Name - Fingolimod Hydrochloride
CEP DMF Filed
Product Name - Sugammadex Sodium
Canada DMF Filed
Product Name - Apremilast Form B
Korea DMF Filed
Product Name - Rabeprazole Sodium [Amorphous]
Korea DMF Filed
Product Name - Sumatriptan Succinate
Korea DMF Filed
Product Name - Enzalutamide
Korea DMF Filed
Product Name - Sacubitril/Valsartan
Korea DMF Filed
Product Name - Pioglitazone Hydrochloride
Korea DMF Filed
Product Name - Montelukast Sodium
Korea DMF Filed
Product Name - Eribulin Mesylate
Australia DMF Filed
Product Name - Molnupiravir
WHO DMF Filed
Product Name - Omeprazole Magnesium
CEP Granted
Product Name - Dasatinib Monohydrate
Japan DMF Filed
Product Name - Fexofenadine Hydrochloride (Form-I)
Brazil DMF Filed
Product Name - Dapagliflozin Amorphous
Brazil DMF Filed
Product Name - Losartan Potassium [Form-I]
Korea DMF Filed
Product Name - Losartan Potassium [Form-I]
Brazil DMF Filed
Product Name - Losartan Potassium [Form 1]
CEP Granted
Product Name - Capecitabine
Japan DMF filed
Product Name - Losartan Potassium
Japan DMF
Product Name - Ticagrelor
Russia DMF
Product Name - Escitalopram Oxalate
CEP Granted
Product Name - Sugammadex Sodium
Taiwan DMF
Product Name - Bempedoic Acid
Brazil DMF
Product Name - Lurasidone Hydrochloride
EU DMF
Product Name - Eribulin Mesylate
EU DMF
Product Name - Nilotinib Hydrochloride
USDMF
Product Name - Tofacitinib Citrate
USDMF
Product Name - Eribulin Mesylate
Canada DMF
Product Name - Palbociclib [Form-A]
Brazil DMF
Product Name - Metoprolol Succinate
CEP Granted
Product Name - Clopidogrel Bisulfate [Form-I] CIP
Brazil DMF
Product Name - Moxifloxacin Hydrochloride USP
Brazil DMF
Product Name - Fexofenadine Hydrochloride
Korea DMF
Product Name - Sitagliptin Phosphate Monohydrate
Korea DMF
Product Name - Clopidogrel Bisulfate [Form-II]
CEP Granted
Product Name - Sitagliptin Phosphate Monohydrate
CEP Granted
Product Name - Sumatriptan Succinate USP
USDMF
Product Name - Atorvastatin Calcium Trihydrate (Form-1)
Brazil DMF
Product Name - Dimethyl Fumarate
Brazil DMF
Product Name - Atorvastatin Calcium Trihydrate (Form-1)
Japan DMF
Product Name - Clopidogrel Bisulfate [Form-II]
EUDMF
Product Name - Linagliptin
EUDMF
Product Name - Linagliptin
Brazil DMF
Product Name - Dimethyl Fumarate
EUDMF
Product Name - Nilotinib Hydrochloride Monohydrate
Brazil DMF
Product Name - Levocetirizine Dihydrochloride
Brazil DMF
Product Name - Clopidogrel Bisulphate (Form - II)
China DMF
Product Name - Ketorolac Tromethamine
China DMF
Product Name - Capecitabine
Japan DMF
Product Name - Dabigatran Etexilate Mesylate
China DMF
Product Name - Naproxen
China DMF
Product Name - Levetiracetam
Korea DMF filed
Product Name - Bendamustine HCl
Canada DMF filed
Product Name - Fexofenadine Form-1
CEP Granted
Product Name - Clopidogrel Bisulphate Form-2
CEP Granted
Product Name - Mirabegron
Europe ASMF filed
Product Name - Permethrin-25:75
CEP Granted
Product Name - Pregabalin
Korea DMF filed
Product Name - Ondansetron Hydrochloride
Korea DMF filed
Product Name - Sitagliptin Phosphate USP (monohydrate)
US DMF filed
Product Name - Hydroxychloroquine Sulfate
US DMF filed
Product Name - Favipiravir
US DMF filed
Product Name - Finasteride (Form-I)
Brazil DMF Available
Product Name - Losartan Potassium
Japan DMF filed
Product Name - Clopidogrel Bi-sulfate (Form-II)
Japan DMF filed
Product Name - Amlodipine Besilate
China DMF filed
Product Name - Abiraterone Acetate
Japan DMF filed
Product Name - Naproxen Sodium
Brazil DMF Available
Product Name - Naproxen
Brazil DMF Available
Product Name - Sitagliptin Phosphate Ph.Eur (monohydrate)
CEP Granted
Product Name - Apalutamide (Amorphous)
US DMF filed
Product Name - Finasteride (Form-I)
China DMF filed
Product Name - Ondansetron base
Brazil DMF Available
Product Name - Rabeprazole Sodium [Amorphous]
Japan DMF filed
Product Name - Dabigatran Etexilate Mesylate
Korea DMF filed
Product Name - Bendamustine Hydrochloride
Brazil DMF Available
Product Name - Sitagliptin Phosphate Monohydrate USP
Brazil DMF Available
Product Name - Rabeprazole Sodium [Amorphous]
China DMF filed
Product Name - Pregabalin
China DMF filed
Product Name - Fingolimod Hydrochloride
China DMF filed
Product Name - Dapagliflozin (Amorphous)
China DMF filed
Product Name - Olaparib
US DMF filed
Product Name - Diroximel Fumarate
US DMF filed
Product Name - Sitagliptin Phosphate Monohydrate USP
US DMF filed
Product Name - Lurasidone HCl
Brazil DMF Available
Product Name - Atorvastatin Calcium Trihydrate [Form-I] ATN process
China DMF filed
Product Name - Rivaroxaban
Korea DMF filed
Product Name - Pazopanib Hydrochloride
US DMF filed
Product Name - Pregabalin
US DMF filed
Product Name - Dimethyl Fumarate
EDMF filed
Product Name - Olanzapine
Korea DMF filed
Product Name - Ropinirole
CEP Granted
Product Name - Rivastigmine HT P-1
CEP Granted
Product Name - Esomeprazole Magnesium Trihydrate
CEP Granted
Product Name - Eribulin Fragment A
US DMF filed
Product Name - Lenvatinib mesylate (Form C)
US DMF filed
Product Name - Dapagliflozin PG Solvate [Micronized]
Korea DMF filed
Product Name - Clopidogrel Bisulphate [Form-II]
Korea DMF filed
Product Name - Olanzapine [Form-I]
Korea DMF filed
Product Name - Levofloxacin (USP) Hemihydrate
Korea DMF filed
Product Name - Azacitidine
Brazil DMF Available
Product Name - Pregabalin
Brazil DMF Available
Product Name - Diluted Everolimus
Brazil DMF Available
Product Name - Atorvastatin Calcium Trihydrate [Form-I] USP
Brazil DMF Available
Product Name - Midostaurin - Crystalline Form II
Brazil DMF Available
Product Name - Edaravone
CEP Granted
Product Name - Ranolazine
CEP Granted
Product Name - Enzalutamide
Brazil DMF Available
Product Name - Metoprolol Succinate FW
Brazil DMF Available
Product Name - Ibandronate Sodium Monohydrate [Form-B]
Brazil DMF Available
Product Name - Enalaprilat
US DMF filed
Product Name - Atorvastatin Calcium [Form-P]
Brazil DMF Available
Product Name - Dabigatran Etexilate Mesilate [Form-2]
Brazil DMF Available
Product Name - Dutasteride [Form-II]
Brazil DMF Available
Product Name - Cinacalcet HCl
China DMF filed
Product Name - Mirabegron (Alpha)
China DMF filed
Product Name - Quetiapine Fumarate (Ph.Eur)
Brazil DMF Available
Product Name - Quetiapine Fumarate (USP)
Brazil DMF Available
Product Name - Rabeprazole Sodium (Form-Y)
Brazil DMF Available
Product Name - Apixaban
China DMF filed
Product Name - Pioglitazone Hydrochloride
Japan DMF filed
Product Name - Atorvastatin Calcium (Amorphous)
Brazil DMF Available
Product Name - Eribulin Mesylate
US DMF filed
Product Name - Sacubitril/Valsartan
China DMF filed
Product Name - Gemcitabine Hydrochloride
China DMF filed
Product Name - Azacitidine
China DMF filed
Product Name - Rivaroxaban (Ph.Eur)
Brazil DMF Available
Product Name - Lenalidomide (LEU1)
Brazil DMF Available
Product Name - Lenalidomide [Form-A]
CEP Granted
Product Name - Moxifloxacin hydrochloride
Brazil DMF Available
Product Name - Mirabegron [Alpha]
Brazil DMF Available
Product Name - Sitagliptin Phosphate MH
Brazil DMF Available
Product Name - Valsartan [Compacted]
Brazil DMF Available
Product Name - Dasatinib SPG Solvate
Brazil DMF Available
Product Name - Atorvastatin Calcium Trihydrate (Form-1)
Canada DMF filed
Product Name - Valsartan
Canada DMF filed
Product Name - Esclicabazepine Acetate
Europe ASMF
Product Name - Abiraterone acetate
Europe ASMF
Product Name - Ticagrelor
Brazil DMF Available
Product Name - Levetiracetam
Brazil DMF Available
Product Name - Clopidogrel Bisulphate Form-1
Brazil DMF Available
Product Name - Sugammadex Sodium
Brazil DMF Available
Product Name - Sitagliptin HCl (CIP)
Korea DMF filed
Product Name - Icatibant Acetate
Europe ASMF
Product Name - Azacitidine
Japan DMF filed
Product Name - Liraglutide
US DMF filed
Product Name - Montelukast Sodium Ph.Eur.
Brazil DMF Available
Product Name - Gemcitabine Hydrochloride
Brazil DMF Available
Product Name - Sertraline HCl (SET4L)
Brazil DMF Available
Product Name - Rivaraoxaban
CEP Granted
Product Name - Keterolac Tromethamine
Brazil DMF Available
Product Name - Ondansetron Hydrochloride
Brazil DMF Available
Product Name - Sitagliptin Phosphate Anhydrous
Brazil DMF Available
Product Name - Apixaban
Brazil DMF Available
Product Name - Naratriptan Hydrochloride
Brazil DMF Available
Product Name - Valsartan [micronized]
Brazil DMF Available
Product Name - Pregabalin
China DMF filed
Product Name - Tizanidine
CEP Granted
Product Name - Losartan K
Brazil DMF Available
Product Name - Ondansetron HCl
China DMF filed
Product Name - Canagliflozin Hemihydrate
China DMF filed
Product Name - Raloxifene HCl
Korea DMF filed
Product Name - Escitalopram Oxalate
Korea DMF filed
Product Name - Ticagrelor
CEP Granted
Product Name - Fexofenadine HCl ( form X)
Japan DMF filed
Product Name - Midostaurin
US DMF filed
Product Name - Divalproex Sodium
Brazil DMF Available
Product Name - Rivaroxaban
Brazil DMF Available
Product Name - Mirabegron Amorphous
Brazil DMF Available
Product Name - Sitagliptin Phosphate (Anhydrous)
China DMF filed
Product Name - Dutasteride (Form-II)
Canada DMF filed
Product Name - Rabeprazole Sodium Hydrate (form-Y) RBL process
CEP Granted
Product Name - Dapagliflozin Propane Diol
Brazil DMF Available
Product Name - Abiraterone Acetate
Brazil DMF Available
Product Name - Sugammadex Sodium
China DMF filed
Product Name - Lurasidone HCl
China DMF filed
Product Name - Raloxifene HCl
China DMF filed
Product Name - Apremilast (Form-B)
China DMF filed
Product Name - Atorvastatin Calcium [Form-1] [ATN]
Korea DMF filed
Product Name - Rabeprazole Sodium (Amorphous)
CEP Granted
Product Name - Pregabalin
Japan DMF filed
Product Name - Famotidine
Japan DMF filed
Product Name - Lenalidomide
US DMF filed
Product Name - Clopidogrel Bisulfate
US DMF filed
Product Name - Roxadustat
US DMF filed
Product Name - Elagolix
US DMF filed
Product Name - Clopidogrel Bisulphate [Form-I] (CIP)
Brazil DMF Available
Product Name - Atorvastatin Calcium Trihydrate [Form-1] [ATN]
Brazil DMF Available
Product Name - Montelukast Sodium USP
Brazil DMF Available
Product Name - Pregabalin
Brazil DMF Available
Product Name - Capecitabine
Brazil DMF Available
Renuncia
Ninguna información en este catálogo, incluida cualquier referencia a cualquier producto o servicio, constituye una oferta de venta, ni debe interpretarse como representación de una oferta de venta. Los productos protegidos por patentes válidas no se ofrecen ni se suministran para uso comercial. Sin embargo, las cantidades de investigación de dichos productos pueden ofrecerse con el fin de presentaciones reglamentarias, siempre que existan dichas exenciones reglamentarias. Los compradores deben realizar una evaluación independiente del escenario de la patente para sus respectivos mercados y serán responsables de todas las responsabilidades relacionadas con la patente. Los productos protegidos por patentes válidas en la India no están disponibles para uso comercial, pero estarían disponibles para los fines de la Sección 107A.